Soligenix reports positive safety review for phase 3 CTCL trial
Tweet Send to a Friend
Soligenix Inc. (NASDAQ: SNGX) announced that its Data Monitoring Committee concluded there are no safety concerns with the ongoing confirmatory ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


